<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR77">
 <label>77</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vegvari</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Hadjichrysanthou</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>CauÃ«t</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Lawrence</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Cori</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>de Wolf</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>RM</given-names>
   </name>
  </person-group>
  <article-title>How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?</article-title>
  <source>PLoS ONE</source>
  <year>2016</year>
  <volume>11</volume>
  <issue>7</issue>
  <fpage>0158237</fpage>
  <lpage>13</lpage>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0158237</pub-id>
 </element-citation>
</ref>
